A CxO view on GAMP 5 Second Edition

Change of business environment Business digitalization brings a wealth of benefits to the Life Sciences [....]

Wlodek Gryglewicz no comments

Incorporate and take advantage of technology trends in Life Sciences.

INTRODUCTION The future of pharmaceutical, biotechnological and medical technology operations has changed, which has improved [....]

Iwona Gryglewicz no comments

Environmental Due Diligence Services for Mergers and Acquisition Activity

What is it About? There are a multitude of risks to deal with and address [....]

Dr Grant Richardson no comments

The importance of GAMP 5, a pragmatic approach to computer systems validation

Introduction. I have now been involved with GAMP COP since the late 90’s and have [....]

Paul Irving no comments

Pharmaceutical & Medical Device Packaging – Compliance and Opportunity

Regulatory compliance in packaging is a fundamental requirement for the Pharmaceutical and Medical Device industries. [....]

Andrew Finch no comments

Innovation & Collaboration with Shodann – Technology Partner

Introduction: In recent years Northern Life Sciences (NLS) have a built a team of experienced [....]

northernlife no comments

Due Diligence Process in Life Sciences.

Some history of the Process Probably the term “due diligence” has been used in 1598 [....]

Wlodek Gryglewicz no comments

Pharmaceutical Operations Today and Near Future – Interview with Theodore Iliopoulos

We have finished our previous meeting discussing the challenges for the industry in near future. [....]

Iwona Gryglewicz no comments

Strategic Planning

“A business strategy for regulated organizations may be considered as the combination of competitive actions [....]

Paul Irving no comments

Project Case Study

It was very encouraging that a company has embraced the principals and concepts within current [....]

Paul Irving no comments